In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
In silico clinical trials, defined as “The use of individualized computer simulation in the development or regulatory evaluation of a medicinal product, medical device, or medical intervention,” have been proposed as a possible strategy to reduce the regulatory costs of innovation and the time to market for biomedical products. We review some of the the literature on this topic, focusing in particular on those applications where the current practice is recognized as inadequate, as for example, the detection of unexpected severe adverse events too rare to be detected in a clinical trial, but still likely enough to be of concern. We then describe with more details two case studies, two successful applications of in silico clinical trial approaches, one relative to the University of Virginia/Padova simulator that the Food and Drug Administration has accepted as possible replacement for animal testing in the preclinical assessment of artificial pancreas technologies, and the second, an investigation of the probability of cardiac lead fracture, where a Bayesian network was used to combine in vivo and in silico observations, suggesting a whole new strategy of in silico-augmented clinical trials, to be used to increase the numerosity where recruitment is impossible, or to explore patients’ phenotypes that are unlikely to appear in the trial cohort, but are still frequent enough to be of concern.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“Two nature reviews written a decade apart point to the rapidly increasing global prevalence of diabetes mellitus as a result of population aging, urbanization, and associated lifestyle changes.(62,63) Between 1980 and 2010, the number of people with diabetes mellitus worldwide has more than doubled.”
BackgroundMeal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
Self-citationThe UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791
Self-citationIn Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Self-citationDHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566
Self-citationEffects of Age and Sex on Postprandial Glucose Metabolism
Basu, R., Dalla Man, C., Campioni, M., Basu, A., Klee, G., Toffolo, G., Cobelli, C., & Rizza, R. A. (2006) · Diabetes · doi:10.2337/db05-1692 · Cited by 334
Self-citationGIM, Simulation Software of Meal Glucose–Insulin Model
Dalla Man, C., Raimondo, D. M., Rizza, R. A., & Cobelli, C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100303 · Cited by 253 · cited 1×
“A model including 18 differential equations with 42 parameters, 33 of which were free and 9 were derived from steadystate constraints, was identified in each individual using a Bayesian forcing function strategy.(78,79) From the model parameter estimates of the 204 subjects participating in this study, the inter-indiv…”
MethodSelf-citationKovatchev, B., Cobelli, C., Renard, E., Anderson, S., Breton, M., Patek, S., Clarke, W., Bruttomesso, D., Maran, A., Costa, S., et al. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400611 · Cited by 200
Self-citation
Cited by
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citationIn silico clinical trials: concepts and early adoptions
Pappalardo, F., Russo, G., Tshinanu, F. M., & Viceconti, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby043 · Cited by 279
Self-citationContinuous glucose monitoring sensors: past, present and future algorithmic challenges
Facchinetti, A. (2016) · Sensors · doi:10.3390/s16122093 · Cited by 176
A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
Kovatchev, B. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.04.008 · Cited by 80
Self-citationCredibility of In Silico Trial Technologies—A Theoretical Framing
Viceconti, M., Juarez, M. A., Curreli, C., Pennisi, M., Russo, G., & Pappalardo, F. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2949888 · Cited by 67
Self-citation
Metadata
- Authors
- Viceconti, M., Cobelli, C., Haddad, T., Himes, A., Kovatchev, B., & Palmer, M.
- Venue
- Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine
- Publisher
- SAGE Publications
- Published
- 2017-04-21
- Volume
- 231
- Issue
- 5
- Pages
- 455-466
- ISSN
- 0954-4119 (ISSN-L)
- 2041-3033
- OpenAlex
- W2606506153
- Cited by
- 64
- References
- 20
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies. https://app.cochat.ai/papers/10.1177/0954411917702931
- The paper
- Viceconti, M., Cobelli, C., Haddad, T., Himes, A., Kovatchev, B., & Palmer, M. (2017). In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. https://doi.org/10.1177/0954411917702931
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.